December 2003
From McGill University
International symposium on tuberous sclerosis Genetic behavioral and surgical aspects You are invited to the press conference marking the opening of the International Symposium on Tuberous Sclerosis: Genetic behavioral and surgical aspects which will be held at the Montreal Neurological Institute and Hospital on December 4, 2003. At the conference more than twenty international experts will discuss the latest advances in understanding the genetic factors involved, as well as behavioural manifestations and surgical treatment.Tuberous Sclerosis Complex (TS) affects about 1 in 6000/10,000 persons in the population, with 1 to 2 million people affected world-wide. TS is a congenital genetic disease that affects a number of organs. It is characterized by skin abnormalities and birthmarks, tuber-like growths in the eyes, the brain, and other internal organs, and varying severity of epilepsy and mental retardation. There is no cure, but treatment is available for some of the symptoms. WHEN: Wednesday December 3, 2003
3:00 pm WHERE: Jeanne Timmins Amphitheatre (follow the signs from the main entrance) Montreal Neurological Institute and Hospital 3801 University Street (Parking is limited, you may park in front of the Royal Victoria on Pine Ave or at the top of University Street) WHO: Dr. Eva Andermann
Director of Neurogenetics, Montreal Neurological Institute and Hospital, Montreal, Canada Dr. Fred Andermann
Director of Epilepsy Service, Montreal Neurological Institute and Hospital, Montreal, Canada Dr. Alexis Arzimanoglou
Head, Epilepsy Program, H�pital Robert Debr�, Paris, France Ms Nancy Bryce
Vice-President & Director of Education, Research and Development Tuberosis Sclerosis Canada scl�rose tubereuse Mr. Ron Hutchison
Board Member, Tuberosis Sclerosis Canada scl�rose tubereuse Dr. Philippe Ryvlin
Professor of Neurology, University of Lyon, France For more information please contact:
Sandra McPherson, Montreal Neurological Institute Tel: 514-398-1902,
Email: [email protected] |